New Studies
Major findings from Lancet, BMJ, NEJM, JAMA, and other leading journals
First In Vivo CRISPR Gene Editing Treatment Shows Promise for Rare Blood Disorder
First clinical trial of in vivo CRISPR gene editing for hereditary angioedema shows promising results. The investigational therapy targets genetic…
Editor's Top Picks
Minocycline Stroke Trial Debate Highlights Neuroprotection Research Challenges
Scientific debate in The Lancet highlights persistent challenges in stroke neuroprotection research following criticism of the EMPHASIS minocycline trial. Researchers…
Submit Your Paper →
More form New Studies
Tomato-Soy Juice Blend Reduces Obesity-Related Inflammation in Clinical Trial
A clinical trial shows that a specially formulated tomato-soy juice reduced obesity-related inflammatory markers by…
Autoimmune Disease Increases Risk of Poor Outcomes in Myelodysplastic Syndrome
New research published in Clinical Immunology establishes preexisting autoimmune disease as an independent risk factor…
Cannabis Edibles and Alcohol Create Hidden Impairment Risk for Drivers, Johns Hopkins Study Reveals
New Johns Hopkins research reveals that combining cannabis edibles with alcohol increases driving impairment 2.8…
Digital Twins of Donor Lungs Could Transform Transplant Medicine
Researchers create digital twins of donor lungs using ex vivo perfusion data, enabling virtual testing…
Breakthrough Drug Shows 75% Response Rate in Hard-to-Treat Lung Cancer
Sunvozertinib achieved a 75% response rate in previously untreated lung cancer patients with EGFR exon…